3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
2
Breast Neoplasms
2
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Prostatic Neoplasms
1
Neoplasms
1
Neoplasm, Residual
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Leukemia
1
Fatigue
1
Depression
1
Colonic Neoplasms
1
Cardiotoxicity
1
Anxiety Disorders
1
Interventions
Leucovorin
38
Fluorouracil
36
Oxaliplatin
34
Bevacizumab
34
Irinotecan
32
Cetuximab
23
Capecitabine
18
Panitumumab
14
IFL protocol
7
Folfox protocol
6
Radiotherapy
5
Nivolumab
5
Magnetic Resonance Spectroscopy
5
Immunohistochemistry
5
Gene Expression Profiling
5
Celecoxib
5
regorafenib
4
pembrolizumab
4
dehydroftorafur
4
Ramucirumab
4
Fluorodeoxyglucose F18
4
Floxuridine
4
aflibercept
3
Surgical Procedures, Operative
3
Sorafenib
3
Radiosurgery
3
Ipilimumab
3
Gemcitabine
3
Fentanyl
3
Drug Therapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Colonic Neoplasms
×
Exercise Test
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts